sb 203580 has been researched along with jte 013 in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (jte 013) | Trials (jte 013) | Recent Studies (post-2010) (jte 013) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 84 | 0 | 60 |
| Protein | Taxonomy | sb 203580 (IC50) | jte 013 (IC50) |
|---|---|---|---|
| Sphingosine 1-phosphate receptor 2 | Homo sapiens (human) | 0.0401 | |
| Sphingosine 1-phosphate receptor 2 | Rattus norvegicus (Norway rat) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, H; Huang, J; Huang, K; Lan, T; Liu, P; Liu, W; Peng, J; Shen, X; Xie, X | 1 |
1 other study(ies) available for sb 203580 and jte 013
| Article | Year |
|---|---|
S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition.
Topics: Animals; Diabetic Nephropathies; Extracellular Matrix; Extracellular Signal-Regulated MAP Kinases; Fibronectins; Flavonoids; Glucose; Hyperglycemia; Imidazoles; Kidney; Lysophospholipids; MAP Kinase Signaling System; Mesangial Cells; p38 Mitogen-Activated Protein Kinases; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; RNA Interference; RNA, Messenger; RNA, Small Interfering; Sphingosine; Sphingosine-1-Phosphate Receptors | 2012 |